Assessment of SpondyloArthritis Society (ASAS) Classification and Diagnostic Criteria for Early Axial Spondyloarthritis (SpA)
Prospective, International, Multi-centre Study on ASAS Classification Criteria for SpA
1 other identifier
observational
992
20 countries
35
Brief Summary
Background: Existing criteria for AS/SpA such as mod. New York, ESSG, or Amor criteria for classification and/or diagnosis of spondyloarthritis have limitations when applied to early disease. Moreover, MRI is not part of any of the established criteria and the precise role of MRI in early axial disease has not been fully defined yet. Even less is known about sacroiliac (SI) changes in SpA patients with peripheral symptoms. A pilot study using data from 'paper patients' led to new candidate criteria for early spondyloarthritis. Subsequently, the members of the ASAS International Working Group decided to conduct a prospective multi-centre study to evaluate (validate) the new candidate criteria, and to assess their performance as diagnostic criteria. Aims of the study:
- 1.To evaluate the new candidate criteria for axial SpA in a multi-centre setting.
- 2.To assess the potential role of the new candidate criteria to be used as diagnostic criteria. To accomplish this, inclusion of consecutive and undiagnosed patients is mandatory as are longer periods of follow-up .
- 3.To compare criteria encompassing the whole group of SpA such as ESSG and Amor criteria against criteria which are tailored to either predominant axial disease or predominant peripheral disease. To accomplish this, both patients with predominant axial disease (back pain) but also patient with predominant peripheral disease (arthritis/enthesitis) will be included.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2006
Longer than P75 for all trials
35 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 18, 2006
CompletedFirst Posted
Study publicly available on registry
May 19, 2006
CompletedStudy Start
First participant enrolled
July 1, 2006
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2013
CompletedFebruary 13, 2013
February 1, 2013
6.9 years
May 18, 2006
February 12, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Diagnosis of Spondyloarthritis
2 years
Secondary Outcomes (1)
Patients with a retained diagnosis of spondyloarthritis after follow-up
2-5 years
Study Arms (1)
Back pain / peripheral arthritis
Patients with chronic back pain of unknown origin and onset of back pain \<45 years of age or patients with peripheral arthritis / enthesitis / dactylitis of unknown origin and onset \<45 years of age
Eligibility Criteria
Patients with chronic back pain of unknown origin or peripheral arthritis / enthesitis / dactylitis of unknown origin who are referred to a rheumatologist for diagnostic work-up
You may qualify if:
- Include newly referred patients if:
- Onset of symptoms (back pain/arthritis/enthesitis) \< 45 years
- Undiagnosed disease with the following symptoms:
- chronic back pain (duration of back pain more than 3 months)
- and/or peripheral arthritis (asymmetric arthritis/predominantly of the lower limbs)
- and/or enthesitis
- and/or dactylitis
You may not qualify if:
- Definite diagnosis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (35)
Case Western Reserve University at MetroHealth Medical Centre
Cleveland, Ohio, 44109, United States
University Hospital Gent
Ghent, B-9000, Belgium
Rheumatology Division
São Paulo, Brazil
University of Alberta
Edmonton, Alberta, T6G 252, Canada
The Toronto Hospital
Toronto, Ontario, ON M5T 2S8, Canada
Chinese PLA General Hospital
Beijing, 100853, China
Third Affiliated Hospital of Sun Yat-sen University
Guangzhou, 510630, China
Division of Rheumatology
Bogotá, Colombia
Hvidovre Hospital, University of Copenhagen
Hvidovre, 2650, Denmark
Service de Rheumatologie
Marseille, France
Rheumatology B Department
Paris, 75014, France
Brandt
Berlin, 12163, Germany
Universitaetsmedizin Berlin, Charité Campus Benjamin-Franklin, Med. Clinic I, Rheumatology, Hindenburgdamm 30
Berlin, 12200, Germany
Rheumazentrum Ruhrgebiet
Herne, 44625, Germany
Géher
Budapest, H-1027, Hungary
Seroja Rheumatic Centre
Semarang, 50241, Indonesia
St. Vincent's Hospital
Dublin, 4, Ireland
University of Florence
Florence, 50122, Italy
Arcispedale S. Maria Nouva
Reggio Emilia, 422100, Italy
Caterina Naclerio
Scafati (SA), Italy
Hospital General de México
Mexico City, DF 06726, Mexico
VU University Medical Center
Amsterdam, 1081 HV, Netherlands
Kennemer Gasthuis, Locatie Deo
HG IJmuiden, 1971, Netherlands
University Hospital Maastricht
Maastricht, 6229 HX, Netherlands
Hospital Universitario "Reina Sofia"
Córdoba, 14004, Spain
Hospital Universitario Gregorio Marañón
Madrid, 28007, Spain
Balgrist University Hospital
Zurich, 8008, Switzerland
Veterans General Hospital Taipei
Beitou Dist. Taipei, 112, Taiwan
Wei
Taichung, 40201, Taiwan
Duruöz
Bornova, 35050, Turkey (Türkiye)
Division of Rheumatology
Elâzığ, Turkey (Türkiye)
Izmir University Hospital
Izmir, Turkey (Türkiye)
Glasgow Royal Infirmary, Queen Elizabeth Building
Glasgow, G31 2 ER, United Kingdom
King George Hospital
Goodmayes, IG3 8YB, United Kingdom
ChapelChapel Allerton Hospital
Leeds, LS7 4SA, United Kingdom
Related Publications (3)
Rudwaleit M, Metter A, Listing J, Sieper J, Braun J. Inflammatory back pain in ankylosing spondylitis: a reassessment of the clinical history for application as classification and diagnostic criteria. Arthritis Rheum. 2006 Feb;54(2):569-78. doi: 10.1002/art.21619.
PMID: 16447233BACKGROUNDRudwaleit M, Sieper J. Positive and negative predictive values from published studies can be misleading for decision-making in clinical practice. Rheumatology (Oxford). 2006 Jun;45(6):779-80; author reply 780-1. doi: 10.1093/rheumatology/kel083. Epub 2006 Apr 4. No abstract available.
PMID: 16595519BACKGROUNDRudwaleit M, van der Heijde D, Landewe R, Listing J, Akkoc N, Brandt J, Braun J, Chou CT, Collantes-Estevez E, Dougados M, Huang F, Gu J, Khan MA, Kirazli Y, Maksymowych WP, Mielants H, Sorensen IJ, Ozgocmen S, Roussou E, Valle-Onate R, Weber U, Wei J, Sieper J. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis. 2009 Jun;68(6):777-83. doi: 10.1136/ard.2009.108233. Epub 2009 Mar 17.
PMID: 19297344DERIVED
Related Links
Biospecimen
DNA and RNA will be collected in selected centres for analysis of candidate gene variants in ankylosing spondylitis/ spondyloarthritis. Serum and plasma sample will be collected for biomarker analysis with special focus on markers of bone metabolism
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Martin Rudwaleit, MD
Universitatsmedizin Berlin, Charité Campus Benjamin-Franklin, Med. Clinic I, Rheumatology, Hindenburgdamm 30, 12200 Berlin, Germany
- PRINCIPAL INVESTIGATOR
Joachim Sieper, MD
Charité Universtaetsmedizin Berlin
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Prof.
Study Record Dates
First Submitted
May 18, 2006
First Posted
May 19, 2006
Study Start
July 1, 2006
Primary Completion
June 1, 2013
Study Completion
June 1, 2013
Last Updated
February 13, 2013
Record last verified: 2013-02